| Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response P Jiang, S Gu, D Pan, J Fu, A Sahu, X Hu, Z Li, N Traugh, X Bu, B Li, J Liu, ... Nature medicine 24 (10), 1550-1558, 2018 | 3071 | 2018 |
| A major chromatin regulator determines resistance of tumor cells to T cell–mediated killing D Pan, A Kobayashi, P Jiang, L Ferrari de Andrade, RE Tay, AM Luoma, ... Science 359 (6377), 770-775, 2018 | 713 | 2018 |
| Antibody-mediated inhibition of MICA and MICB shedding promotes NK cell–driven tumor immunity L Ferrari de Andrade, RE Tay, D Pan, AM Luoma, Y Ito, S Badrinath, ... Science 359 (6383), 1537-1542, 2018 | 379 | 2018 |
| Discovery of specialized NK cell populations infiltrating human melanoma metastases LF de Andrade, Y Lu, A Luoma, Y Ito, D Pan, JW Pyrdol, CH Yoon, ... Jci Insight 4 (23), 2019 | 96 | 2019 |
| Cutting edge: Smad2 and Smad4 regulate TGF-β–mediated Il9 gene expression via EZH2 displacement A Wang, D Pan, YH Lee, GJ Martinez, X Feng, C Dong The Journal of Immunology 191 (10), 4908-4912, 2013 | 86 | 2013 |
| Inhibition of MICA and MICB shedding elicits NK-cell–mediated immunity against tumors resistant to cytotoxic T cells L Ferrari de Andrade, S Kumar, AM Luoma, Y Ito, PH Alves da Silva, ... Cancer immunology research 8 (6), 769-780, 2020 | 84 | 2020 |
| Dectin-3 deficiency promotes colitis development due to impaired antifungal innate immune responses in the gut T Wang, D Pan, Z Zhou, Y You, C Jiang, X Zhao, X Lin PLoS pathogens 12 (6), e1005662, 2016 | 82 | 2016 |
| Augmenting NK cell-based immunotherapy by targeting mitochondrial apoptosis R Pan, J Ryan, D Pan, KW Wucherpfennig, A Letai Cell 185 (9), 1521-1538. e18, 2022 | 75 | 2022 |
| MALT1 is required for EGFR-induced NF-κB activation and contributes to EGFR-driven lung cancer progression D Pan, C Jiang, Z Ma, M Blonska, MJ You, X Lin Oncogene 35 (7), 919-928, 2016 | 63 | 2016 |
| The CBM complex underwrites NF-κB activation to promote HER2-associated tumor malignancy D Pan, Y Zhu, Z Zhou, T Wang, H You, C Jiang, X Lin Molecular Cancer Research 14 (1), 93-102, 2016 | 41 | 2016 |
| Inhibition of MAN2A1 Enhances the Immune Response to Anti–PD-L1 in Human Tumors S Shi, S Gu, T Han, W Zhang, L Huang, Z Li, D Pan, J Fu, J Ge, M Brown, ... Clinical Cancer Research 26 (22), 5990-6002, 2020 | 29 | 2020 |
| Tumor aerobic glycolysis confers immune evasion through modulating sensitivity to T cell-mediated bystander killing via TNF-α L Wu, Y Jin, X Zhao, K Tang, Y Zhao, L Tong, X Yu, K Xiong, C Luo, J Zhu, ... Cell Metabolism 35 (9), 1580-1596. e9, 2023 | 25 | 2023 |
| Ubc9 is required for positive selection and late-stage maturation of thymocytes A Wang, X Ding, M Demarque, X Liu, D Pan, H Xin, B Zhong, X Wang, ... The Journal of Immunology 198 (9), 3461-3470, 2017 | 24 | 2017 |
| The CARMA3-BCL10-MALT1 (CBM) complex contributes to DNA damage-induced NF-κB activation and cell survival S Zhang, D Pan, XM Jia, X Lin, X Zhao Protein & Cell 8 (11), 856-860, 2017 | 21 | 2017 |
| Epithelial Growth Factor Receptor–Activated Nuclear Factor κB Signaling and Its Role in Epithelial Growth Factor Receptor–Associated Tumors D Pan, X Lin The Cancer Journal 19 (6), 461-467, 2013 | 21 | 2013 |
| Diversity and prevalence of the C-terminal region of Plasmodium falciparum merozoite surface protein 1 in China D Pan, J Hu, Q Ma, W Pan, M Li Acta tropica 116 (3), 200-205, 2010 | 8 | 2010 |
| Methods for sensitizing cancer cells to T cell-mediated killing by modulating molecular pathways D Pan, KW Wucherpfennig US Patent 11,820,822, 2023 | 2 | 2023 |
| Addressing Tumor Heterogeneity by Sensitizing Resistant Cancer Cells to T cell–Secreted Cytokines Y Ito, D Pan, W Zhang, X Zhang, TY Juan, JW Pyrdol, O Kyrysyuk, ... Cancer discovery 13 (5), 1186-1209, 2023 | 1 | 2023 |
| Methods for sensitizing cancer cells to t cell-mediated killing by modulating molecular pathways D Pan, KW Wucherpfennig US Patent App. 18/234,229, 2024 | | 2024 |
| Abstract B077: Signatures of T-cell dysfunction and exclusion predict cancer immunotherapy response P Jiang, S Gu, D Pan, J Fu, A Sahu, X Hu, Z Li, N Traugh, X Bu, B Li, J Liu, ... Cancer Immunology Research 7 (2_Supplement), B077-B077, 2019 | | 2019 |
Zhicheng ZhouPostdoc of MD anderson cancer centerVerified email at mdanderson.org
